Amphotericin B Injection — FDA Drug Shortage
The FDA lists a drug shortage record for Amphotericin B Injection (injection) from Leadiant Biosciences, Inc. with status To Be Discontinued. The shortage was first posted on 08/08/2025.
Shortage Details
- Status
- To Be Discontinued
- Company
- Leadiant Biosciences, Inc.
- Package NDC
- 57665-101-41
- Dosage Form
- Injection
- Presentation
- Abelcet, Injection, 5 mg/1 mL; 3.4 mg/1 mL; 1.5 mg/1 mL (NDC 57665-101-41)
- Initial Posting
- 08/08/2025
- Revised Date